Plain-English translation of NCT07511205 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a Phase 1 trial testing a new medication called for the first time in humans. Researchers want to understand how safe the medication is, how your body processes it, and how it affects weight-related markers. The study will enroll healthy adults who are overweight or living with obesity.
Currently, there are limited medication options for weight management, and researchers are exploring new treatments that might help. This early-stage trial is designed to see whether this new treatment is safe enough and effective enough to pursue further development.
You likely qualify if…
You likely don't qualify if…
You'll go through a screening period of up to 5 weeks, during which researchers will check your health and confirm you're eligible. If you qualify, you'll be randomly assigned to receive either the new medication or a placebo (inactive substance). Depending on which part of the study you join, you may receive a single dose or multiple doses over time, given as an injection under the skin or intravenously. You'll have follow-up visits to monitor your safety and measure how your body responds to the treatment.
AI-generated summary from trial data · Sep 15, 2026 · Not medical advice
United States
United Kingdom